Israel Grilo Bensusan
Research Subjects
Israel Grilo Bensusan has a total of 68 co-authors. Here are the top co-authors by number of shared publications:
- Francisco Ortega-Ruiz
Medical-Surgical Unit of Respiratory Diseases, University Hospital Virgen del Rocío, 41013 Seville, Spain
4 shared publications - Antonio Grilo
Medicina Interna, Hospital Virgen de Valme
3 shared publications Juan Manuel Pascasio
UCG Aparato Digestivo, Hospital Virgen del Rocio
3 shared publicationsLeonor Gómez-Regife
3 shared publications- Miguel Angel Gomez Bravo
Department of Surgery, Hospital Universitario Virgen del Rocío, 41013 Sevilla, Spain
3 shared publications Francisco-Jesús López-Pardo
Cardiología, Hospital Virgen del Rocio
2 shared publications
Latest Publications
- Open Access
- 12 May 2025
- Published by Sulime Diseno de Soluciones in Revista Andaluza de Patología Digestiva
- Vol. 48 (2) , 80-81
Transanal extraction of a giant calcified fecaloma
Fecalomas are a common complication of chronic constipation, but cases of calcified fecal material due to long-standing impaction are rarely reported. Here, we present a case of a giant calcified fecaloma where conventional extraction methods were unsuccessful. However, we were able to avoid the need for laparotomy and bowel resection by performing a successful transanal extraction.
- 12 May 2025
- Published by Sulime Diseno de Soluciones in Revista Andaluza de Patología Digestiva
- Vol. 48 (2) , 80-81
Open AccessTransanal extraction of a giant calcified fecaloma
Fecalomas are a common complication of chronic constipation, but cases of calcified fecal material due to long-standing impaction are rarely reported. Here, we present a case of a giant calcified fecaloma where conventional extraction methods were unsuccessful. However, we were able to avoid the need for laparotomy and bowel resection by performing a successful transanal extraction.
- Open Access
- 12 May 2025
- Published by Sulime Diseno de Soluciones in Revista Andaluza de Patología Digestiva
- Vol. 48 (2) , 51-58
Microscopic colitis
Microscopic colitis is a chronic inflammatory condition of the colon, primarily presenting with persistent diarrhea. This term refers to two specific subtypes: lymphocytic colitis and collagenous colitis. Both have seen a rise in incidence and prevalence in recent years. Although the exact cause is still unknown, research has identified several risk factors that can help guide the diagnosis. The condition is typically diagnosed through colonoscopy and confirmed by specific histological findings from colon biopsies, as other diagnostic tests mainly serve to exclude alternative causes. Budesonide is the treatment of choice for inducing remission, and in many cases, long-term maintenance therapy is also required. This discussion will emphasize the latest updates in microscopic colitis, focusing on practical applications. We will particularly highlight recent clinical guidelines and the importance of close collaboration between Gastroenterology and Pathology in managing this condition.
- 12 May 2025
- Published by Sulime Diseno de Soluciones in Revista Andaluza de Patología Digestiva
- Vol. 48 (2) , 51-58
Open AccessMicroscopic colitis
Microscopic colitis is a chronic inflammatory condition of the colon, primarily presenting with persistent diarrhea. This term refers to two specific subtypes: lymphocytic colitis and collagenous colitis. Both have seen a rise in incidence and prevalence in recent years. Although the exact cause is still unknown, research has identified several risk factors that can help guide the diagnosis. The condition is typically diagnosed through colonoscopy and confirmed by specific histological findings from colon biopsies, as other diagnostic tests mainly serve to exclude alternative causes. Budesonide is the treatment of choice for inducing remission, and in many cases, long-term maintenance therapy is also required. This discussion will emphasize the latest updates in microscopic colitis, focusing on practical applications. We will particularly highlight recent clinical guidelines and the importance of close collaboration between Gastroenterology and Pathology in managing this condition.
- 3 July 2023
- Published by Sociedad Andaluza de Patologia Digestiva (SAPD) in Revista Andaluza de Patología Digestiva
- Vol. 46 (3) , 132-144
Alternatives to Proton Pump Inhibitors for the treatment of gastroesophageal reflux disease and functional dyspepsia
Resumen Los inhibidores de la bomba de protones (IBP) constituyen un grupo farmacológico ampliamente usado para el tratamiento de la patología esófago-gástrica funcional. Sin embargo, no siempre consiguen el control de los síntomas de dichos procesos, debido a que su fisiopatología no se reduce a la secreción ácida del estómago. Por tanto, el uso exclusivamente de los IBP provocaría en muchos casos un fracaso terapéutico o una respuesta insatisfactoria para el paciente. En esta revisión se presentarán las alternativas médicas al tratamiento con IBP en la enfermedad por reflujo gastroesofágico y en la dispepsia funcional. Se presentarán aquellos fármacos o productos disponibles en nuestro medio o en otros países, que han demostrado su papel en el tratamiento de dichos procesos. Se hará referencia al contexto en el que pueden ser útiles, la posología, los efectos secundarios más relevantes y las evidencias que recomiendan su uso. El conocimiento de estas alternativas permitirá un abordaje más completo y con mayor probabilidad de éxito en el tratamiento de estas patologías. Ambas constituyen un motivo de consulta habitual en el ámbito de la Atención Primaria y en la consulta especializada de Aparato Digestivo.
- 3 July 2023
- Published by Sociedad Andaluza de Patologia Digestiva (SAPD) in Revista Andaluza de Patología Digestiva
- Vol. 46 (3) , 132-144
Alternatives to Proton Pump Inhibitors for the treatment of gastroesophageal reflux disease and functional dyspepsia
Resumen Los inhibidores de la bomba de protones (IBP) constituyen un grupo farmacológico ampliamente usado para el tratamiento de la patología esófago-gástrica funcional. Sin embargo, no siempre consiguen el control de los síntomas de dichos procesos, debido a que su fisiopatología no se reduce a la secreción ácida del estómago. Por tanto, el uso exclusivamente de los IBP provocaría en muchos casos un fracaso terapéutico o una respuesta insatisfactoria para el paciente. En esta revisión se presentarán las alternativas médicas al tratamiento con IBP en la enfermedad por reflujo gastroesofágico y en la dispepsia funcional. Se presentarán aquellos fármacos o productos disponibles en nuestro medio o en otros países, que han demostrado su papel en el tratamiento de dichos procesos. Se hará referencia al contexto en el que pueden ser útiles, la posología, los efectos secundarios más relevantes y las evidencias que recomiendan su uso. El conocimiento de estas alternativas permitirá un abordaje más completo y con mayor probabilidad de éxito en el tratamiento de estas patologías. Ambas constituyen un motivo de consulta habitual en el ámbito de la Atención Primaria y en la consulta especializada de Aparato Digestivo.
- 1 January 2017
- Published by Sociedad Espanola de Patologia Digestiva (SEPD) in Revista Española de Enfermedades Digestivas
- Vol. 109 (12) , 843-849
Hepatopulmonary syndrome: which blood gas analysis criteria and position should we use for diagnosis?
Different blood gas criteria have been used in the diagnosis of hepatopulmonary syndrome (HPS). Arterial blood gases were prospectively evaluated in 194 cirrhotic candidates for liver transplantation (LT) in the supine and seated position. Three blood gas criteria were analyzed: classic (partial pressure of oxygen [PaO2] < 70 mmHg and/or alveolar-arterial gradient of oxygen [A-a PO2] ≥ 20 mmHg), modern (A-a PO2 ≥ 15 mmHg or ≥ 20 mmHg in patients over 64) and the A-a PO2 ≥ threshold value adjusted for age. The prevalence of HPS in the supine and seated position was 27.8% and 23.2% (classic), 34% and 25.3% (modern) and 22.2% and 19% (adjusted for age), respectively. The proportion of severe and very severe cases increased in a seated position (11/49 [22.4%] vs 5/66 [7.6%], p = 0.02). No difference was observed in the pre-LT, post-LT and overall mortality in patients with HPS, regardless of the criteria used. Obtaining blood gas measurements in the supine position and the use of modern criteria are more sensitive for the diagnosis of HPS. Blood gas analysis with the patient seated detects a greater number of severe and very severe cases. The presence of HPS was not associated with an increase in mortality regardless of blood gas criterion used.
- 1 January 2017
- Published by Sociedad Espanola de Patologia Digestiva (SEPD) in Revista Española de Enfermedades Digestivas
- Vol. 109 (12) , 843-849
Hepatopulmonary syndrome: which blood gas analysis criteria and position should we use for diagnosis?
Different blood gas criteria have been used in the diagnosis of hepatopulmonary syndrome (HPS). Arterial blood gases were prospectively evaluated in 194 cirrhotic candidates for liver transplantation (LT) in the supine and seated position. Three blood gas criteria were analyzed: classic (partial pressure of oxygen [PaO2] < 70 mmHg and/or alveolar-arterial gradient of oxygen [A-a PO2] ≥ 20 mmHg), modern (A-a PO2 ≥ 15 mmHg or ≥ 20 mmHg in patients over 64) and the A-a PO2 ≥ threshold value adjusted for age. The prevalence of HPS in the supine and seated position was 27.8% and 23.2% (classic), 34% and 25.3% (modern) and 22.2% and 19% (adjusted for age), respectively. The proportion of severe and very severe cases increased in a seated position (11/49 [22.4%] vs 5/66 [7.6%], p = 0.02). No difference was observed in the pre-LT, post-LT and overall mortality in patients with HPS, regardless of the criteria used. Obtaining blood gas measurements in the supine position and the use of modern criteria are more sensitive for the diagnosis of HPS. Blood gas analysis with the patient seated detects a greater number of severe and very severe cases. The presence of HPS was not associated with an increase in mortality regardless of blood gas criterion used.
- 1 January 2017
- Published by Sociedad Espanola de Patologia Digestiva (SEPD) in Revista Española de Enfermedades Digestivas
The utility of the macro-aggregated albumin lung perfusion scan in the diagnosis and prognosis of hepatopulmonary syndrome in cirrhotic patients candidates for liver transplantation
The macro-aggregated albumin lung perfusion scan (99mTc-MAA) is a diagnostic method for hepatopulmonary syndrome (HPS).
- 1 January 2017
- Published by Sociedad Espanola de Patologia Digestiva (SEPD) in Revista Española de Enfermedades Digestivas
The utility of the macro-aggregated albumin lung perfusion scan in the diagnosis and prognosis of hepatopulmonary syndrome in cirrhotic patients candidates for liver transplantation
The macro-aggregated albumin lung perfusion scan (99mTc-MAA) is a diagnostic method for hepatopulmonary syndrome (HPS).
- 1 January 2016
- Published by Sociedad Espanola de Patologia Digestiva (SEPD) in Revista Española de Enfermedades Digestivas
- Vol. 108 (12) , 765-769
Prospective study of anxiety in patients undergoing an outpatient colonoscopy
Undergoing a colonoscopy can cause anxiety in patients and this is something which has not been closely studied. To determine the frequency and intensity of anxiety prior to a colonoscopy and the factors which are related to the procedure. This is a prospective study of patients undergoing outpatient colonoscopy in our hospital. Anxiety was assessed using a visual analogue scale of 0 to 100. The severity of anxiety was rated as mild (1-29), moderate (30-79) or severe (80-100). Three hundred and twenty-seven patients completed the study, of whom 154 (47.1%) were men with a median age of 54 years (p25-75: 45-65). Three hundred and nine (94.5%) patients were found to suffer a certain degree of anxiety. The median value on the visual analogue scale was 31 (p25-75: 10-53). Anxiety levels were mild in 136 patients (44%), moderate in 141 (45.6%) and severe in 32 (10.4%). Greater anxiety was associated with female patients (mean 40.38 vs 31.99, p = 0.01) and a poorly tolerated previous colonoscopy (mean 50.67 vs 28.44, p = 0.01) and correlated inversely with age (r = -0.170, p = 0.02). Colonoscopy causes some degree of anxiety in most patients. Being female, younger and having experienced poor tolerance to a previous scan are associated with greater degrees of anxiety. These findings should be taken into account in the implementation of measures to improve the quality and tolerance of colonoscopy.
- 1 January 2016
- Published by Sociedad Espanola de Patologia Digestiva (SEPD) in Revista Española de Enfermedades Digestivas
- Vol. 108 (12) , 765-769
Prospective study of anxiety in patients undergoing an outpatient colonoscopy
Undergoing a colonoscopy can cause anxiety in patients and this is something which has not been closely studied. To determine the frequency and intensity of anxiety prior to a colonoscopy and the factors which are related to the procedure. This is a prospective study of patients undergoing outpatient colonoscopy in our hospital. Anxiety was assessed using a visual analogue scale of 0 to 100. The severity of anxiety was rated as mild (1-29), moderate (30-79) or severe (80-100). Three hundred and twenty-seven patients completed the study, of whom 154 (47.1%) were men with a median age of 54 years (p25-75: 45-65). Three hundred and nine (94.5%) patients were found to suffer a certain degree of anxiety. The median value on the visual analogue scale was 31 (p25-75: 10-53). Anxiety levels were mild in 136 patients (44%), moderate in 141 (45.6%) and severe in 32 (10.4%). Greater anxiety was associated with female patients (mean 40.38 vs 31.99, p = 0.01) and a poorly tolerated previous colonoscopy (mean 50.67 vs 28.44, p = 0.01) and correlated inversely with age (r = -0.170, p = 0.02). Colonoscopy causes some degree of anxiety in most patients. Being female, younger and having experienced poor tolerance to a previous scan are associated with greater degrees of anxiety. These findings should be taken into account in the implementation of measures to improve the quality and tolerance of colonoscopy.
- Open Access
- 1 January 2016
- Published by Baishideng Publishing Group Inc. in World Journal of Gastroenterology
- Vol. 22 (25) , 5728-41
Hepatopulmonary syndrome: What we know and what we would like to know
Hepatopulmonary syndrome (HPS) is characterized by abnormalities in blood oxygenation caused by the presence of intrapulmonary vascular dilations (IPVD) in the context of liver disease, generally at a cirrhotic stage. Knowledge about the subject is still only partial. The majority of the information about the etiopathogenesis of HPS has been obtained through experiments on animals. Reported prevalence in patients who are candidates for a liver transplantation (LT) varies between 4% and 32%, with a predominance of mild or moderate cases. Although it is generally asymptomatic it does have an impact on their quality of life and survival. The diagnosis requires taking an arterial blood gas sample of a seated patient with alveolar-arterial oxygen gradient (AaO2) ≥ 15 mm Hg, or ≥ 20 mm Hg in those over 64 years of age. The IPVD are identified through a transthoracic contrast echocardiography or a macroaggregated albumin lung perfusion scan (99mTc-MAA). There is currently no effective medical treatment. LT has been shown to reverse the syndrome and improve survival rates, even in severe cases. Therefore the policy of prioritizing LT would appear to increase survival rates. This paper takes a critical and clinical look at the current understanding of HPS, as well as the controversies surrounding it and possible future research.
- 1 January 2016
- Published by Baishideng Publishing Group Inc. in World Journal of Gastroenterology
- Vol. 22 (25) , 5728-41
Open AccessHepatopulmonary syndrome: What we know and what we would like to know
Hepatopulmonary syndrome (HPS) is characterized by abnormalities in blood oxygenation caused by the presence of intrapulmonary vascular dilations (IPVD) in the context of liver disease, generally at a cirrhotic stage. Knowledge about the subject is still only partial. The majority of the information about the etiopathogenesis of HPS has been obtained through experiments on animals. Reported prevalence in patients who are candidates for a liver transplantation (LT) varies between 4% and 32%, with a predominance of mild or moderate cases. Although it is generally asymptomatic it does have an impact on their quality of life and survival. The diagnosis requires taking an arterial blood gas sample of a seated patient with alveolar-arterial oxygen gradient (AaO2) ≥ 15 mm Hg, or ≥ 20 mm Hg in those over 64 years of age. The IPVD are identified through a transthoracic contrast echocardiography or a macroaggregated albumin lung perfusion scan (99mTc-MAA). There is currently no effective medical treatment. LT has been shown to reverse the syndrome and improve survival rates, even in severe cases. Therefore the policy of prioritizing LT would appear to increase survival rates. This paper takes a critical and clinical look at the current understanding of HPS, as well as the controversies surrounding it and possible future research.
- Open Access
- 1 January 2016
- Published by Sociedad Espanola de Patologia Digestiva (SEPD) in Revista Española de Enfermedades Digestivas
- Vol. 108 (4)
Diarrhea caused by multiparasitic infection
Diarrhoea caused by multiple nematode infection is uncommon in Spain, therefore we are not very familiar with the diagnosis and treatment of these patients.
- 1 January 2016
- Published by Sociedad Espanola de Patologia Digestiva (SEPD) in Revista Española de Enfermedades Digestivas
- Vol. 108 (4)
Open AccessDiarrhea caused by multiparasitic infection
Diarrhoea caused by multiple nematode infection is uncommon in Spain, therefore we are not very familiar with the diagnosis and treatment of these patients.
- Open Access
- 14 April 2014
- Published by Elsevier in American Journal of Transplantation
- Vol. 14 (6) , 1391-1399
Prevalence and Severity of Hepatopulmonary Syndrome and Its Influence on Survival in Cirrhotic Patients Evaluated for Liver Transplantation
- 14 April 2014
- Published by Elsevier in American Journal of Transplantation
- Vol. 14 (6) , 1391-1399
Open AccessPrevalence and Severity of Hepatopulmonary Syndrome and Its Influence on Survival in Cirrhotic Patients Evaluated for Liver Transplantation